CYP1A2 and psychiatric disorder: The present study involving patients with psychiatric disorders investigated the role of CYP1A2 and CYP2D6 genetic variants and patients’ CYP1A2 metabolic capacity influenced by non-genetic factors (e.g., sex, age, smoking behaviour) in olanzapine exposure.